Giant cell tumor gct of bone is a locally aggressive benign neoplasm that is associated with a large biological spectrum ranging from latent benign to highly recurrent and occasionally metastatic malignant bone tumor. The surgical treatment of stage iii or aggressive giant cell tumour of the bone, whether to perform intralesional or enbloc resection, remains controversial. Multiple giant cell tumors and paget disease of bone. However, for unknown reasons, this tumour occurs 2 to 3 times more often in southern india and china where giant cell tumours of the bone make up a much larger 20% of all primary bone tumour cases1,3 some reports show a higher number of giant cell tumour of the bone cases in female patients than. Pdf giant cell tumors gct are benign tumors with potential for aggressive behavior and capacity to metastasize. The following list of medications are in some way related to, or used in the treatment of this condition. Giant cell tumor gct of bone is a locally destructive tumor that occurs predominantly in long bones of postpubertal adolescents and young adults, where it occurs in the epiphysis. If you continue browsing the site, you agree to the use of cookies on this website.
A rare bone sarcoma characterized by a usually benign spaceoccupying lesion, which is nevertheless locally aggressive and massively damaging to surrounding bone tissue. Giant cell tumor of the fourth metacarpal bone showing permeative growth pattern. Giant cell tumor orthopaedicsone articles orthopaedicsone. Giant cell tumours gct are benign noncancerous tumours that develop in the bone.
Cytochemical and ultrastructural changes in the osteoclastlike giant cells of giant cell tumor of bone following bisphosphonate administration. Although rarely lethal, benign bone tumors may be associated with a substantial. The key words giant cell tumor, pelvis were used to identify articles which included data on patients with pelvic gcts in english and chinese databases of published reports from 1949. Malignant transformation of a giant cell tumor of bone treated with denosumab. H3f3a gene mutations producing mutant histone protein product h3. Cureus a rare giant cell tumor of the distal fibula and. Pathologic fracture is present in 510% of giant cell tumours. Giant cell tumor of the bones of the hand and foot. Giant cell tumour gct of the distal fibula is extremely rare and poses challenges in the surgical management. Malignant transformation in a histologically typical giant cell tumor of bone, without radiotherapy exposure, is an. Wittig, i am writing at a loss to find adequate words to thank you for all that you have done for me. A giant cell tumor of bone is a primary benign but locally aggressive neoplasm. Also, it can be multicentric in less than 1% of patients.
Although any bone can be involved, the most common sites include the distal femur, proximal tibia, distal radius, sacrum, and proximal humerus. Giant cell tumor of bone gct is a benign locally aggressive neoplasm composed of mononuclear cells admixed with innumerable osteoclasttype giant cells. You were so generous to give up your time on a weekend to operate on my femur. Giant cell tumors of the bone are rare, and no statistics are available about how often they occur in. Sarcomatous transformation is rare and typically occurs with a history of recurrences and radiation treatment. Pdf aggressive giant cell tumor of bone researchgate. Although benign, it can rarely metastasize especially to the lungs.
Giant cell tumors are common, comprising 1823% of benign bone neoplasms and 49. Less than 5% of patients with benign giant cell tumor develop metastases, usually to lungs. For giant cell tumor of bone, the accepted approach of treatment is intralesional curettage with or without adjuvant therapy, leaving en bloc resection as an alternative in recalcitrant or. Pdf pulmonary metastases of giant cell tumor of the bone. However, in large series of patients, such as those of the mayo clinic dahlin, 1981 they constitute 5% of the total number of bone tumors and if grouped with the benign lesions, constitute 20%. A host bony trabecula is embedded in a giant cell tumor proliferation. Secondary malignancy in giant cell tumor of bone arising after treatment of a benign giant cell tumor has a poor prognosis akin to other high grade sarcomas and much worse than primary malignancy in giant cell tumor of bone cancer 2003. One patient patient 4 with a giant cell tumor of the distal radius later had a giant cell tumor develop adjacent to the bone graft site iliac crest, which was labeled recurrent and was included in the 10 recurrent tumors mentioned. Pdf giant cell tumor of bone revisited researchgate. Many authors reported a strong association between radiation therapy and malignant transformation of the giant cell tumor gct. Giant cell tumor gct is a benign, locally aggressive primary bone tumor. Giant cell tumor definition of giant cell tumor by. Genetically, 80% of individuals with giant cell tumor of bone exhibit the cytogenetic abnormality of teleomeric associations tas, whereas half of the cells in the tumor show the tas abnormality 1,31.
Giant cell tumor of bone gctb is a relatively rare, benign but locally aggressive osteolytic skeletal neoplasm of young adults. Giant cell tumor of bone an overview abstract giant cell tumors gct are benign tumors with potential for aggressive behavior and capacity to metastasize. Soucacos first department of orthopaedics, national and kapodistrian university of athens, school of medicine, attikon university hospital. It accounts for 410% of all bone tumors and typically affects the metaepiphyseal region of long bones of young adults. The majority are treated by aggressive curettage or resection.
Malignancy in giant cell tumor of bone bertoni 2003 cancer. Giant cell tumors of the bone are benign multinucleated cell masses that are commonly found at the epiphyses and sometimes the metaphyses of long bones. Giant cell tumor of bone radiology reference article. Giantcell tumor of bone gctb is a locally aggressive, benign osteolytic tumor in which bone destruction is mediated by rank ligand rankl. The tumor is composed of giant multinucleated cells osteoclastlike cells, mononuclear macrophages, and mononuclear stromal cells which secrete promyeloid and pro. Giant cell tumor, or osteoclastoma, usually develops in patients 20 to 50 years old. Denosumab, an inhibitor of the rank ligand involved in bone resorption in gct, is increasingly used in treatment of recurrent or unresectable giant. These tumors are called giant cell tumors of the tendon sheath. On the other hand, according to dispersal nature of bone tumor, i have written a brief paper about bony giant cell tumor because of the importance of this tumor, its.
A brief note on giant cell tumor of bone medcrave online. They mostly occur in the long bones found in the arms and legs. After a wide resection, no recurrences were reported after 39 months of follow. Giant cell tumors gct are benign tumors with potential for aggressive behavior and.
Softtissue recurrence of giantcell tumor of bone after irradiation and excision. A favorable clinical outcome is expected when the tumor is excised to tumorfree margins, however, for periarticular lesions this is usually. They almost invariably 9799% occur when the growth plate has closed and are therefore typically seen in early adulthood. Although the location of tumor was helpful information, radiographic features were not specific. Giant cell tumor gct of bone is a generally benign, but often locally aggressive, neoplasm of bone, with a propensity for recurrence. Subsequent studies examined the effect of megavoltage radiation and showed it to be well tolerated and not associated with malignant. Giant cell tumor of bone genetic and rare diseases. In studies performed by campanacci and dahlin on bone gcts 327 and 195 cases, respectively, incidence of calcaneal gct was found to be less than 1% it is generally seen in the age group of 3040 years and shows high recurrence rate and potentially aggressive features we report the case of a 17yearold female with calcaneal gct. Giant cell tumors of the bone are found predominantly in the epiphysis and metaphysis of. In addition to wide excision, preservation of ankle. In the past 6 years, studies have been done to investigate the clinical effect of denosumab on giant cell tumor of bone, suggesting that it might be a promising adjuvant therapy by reducing osteoclast activity. Giant cell tumor of bone gctb, a primary tumor of bone, frequently occurs in metaphysis of long bones, especially in the distal femur and proximal tibia 1,2.
Malignancies in giant cell tumors of bone always are high. Giant cell tumors of the bone with pulmonary metastasis. Giant cell tumor of bone dr milind merchant slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. A giant cell tumor gct of the bone is a benign but locally aggressive bone tumor. Pdf giant cell tumor of bone an overview researchgate. Giant cell tumors may also be found in the soft tissue surrounding joints, usually forming in the hands and fingers. Present da, bertoni f, springfield d, braylan r, enneking wf. Cooper in 1818 first described giant cell tumors gct of the bone 1. Osteoclastoma definition of osteoclastoma by medical. Rare malignant transformation of benign lesion may be observed with or without use of adjuvant radiotherapy. Tumors are also called neoplasms, which means that they are composed of new and actively growing tissue. These tumors get their name due to the large cell appearance they have when viewing them under a microscope. A giant cell tumor of bone is a type of benign noncancerous tumor that typically occurs in young adults between the ages of 20 and 40. The rank pathway is often reported to be involved in.
Most often, the tumors occur close to the knee jointat the lower end of the thighbone femur or the upper end of the shinbone tibia. Diffuse type tenosynovial giant cell tumor or diffuse type tsgct is a benign soft tissue tumor that typically affects the leg particularly the knee joint. It has a high recurrence rate after surgery with involvement of joints and their surrounding soft. Expression of ezrin, cd44, and vegf in giant cell tumor of. Although they are benign, gct can grow fast and damage the affected bone and spread to the soft tissue around it. Giant cell tumor of bone an overview the archives of bone and. Of 327 patients who had a giantcell tumor of bone and were seen at the istituto rizzoli, 293 were t. Gct mostly affects people between the ages of 20 and 30 years old. Its typical subarticular location and high recurrence risk can be associated with significant morbidity.
It appears most commonly at the ends of tubular long bones, usually in closed epiphyses around the knee and the distal. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. Recent investigations of the specific role of the cell populations present in giant cell tumor of bone that influence tumor proliferation, bone resorption, and its clinical behavior are described. The rankl inhibitor denosumab is being investigated for treatment of gctb. The excised bone gap needs reconstruction using tricortical iliac autograft and supportive plate fixation. Giant cell tumors of bone are uncommon lesions in general orthopedic practice.
Giant cell tumour of the bone bone cancer research trust. They are always found at the end of the bone next to the joint. Denosumab induces tumor reduction and bone formation in. List of giant cell tumor of bone medications 2 compared. We describe histologic analyses of gctb tumor samples from a phase ii study of denosumab in gctb.
Vascular invasion outside the boundary of the tumor can be seen. Giant cell tumor of bone slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. Pdf giant cell tumor gct of bone is a locally aggressive benign neoplasm. Giant cell tumor of bone with pulmonary and lymph node metastases. Giant cell tumor of the bones of the hand and foot biscaglia 2000. Two cases of sarcoma arising in giant cell tumor of bone.
Metastasis, with identical morphology to the primary tumor, occurs in a few percent. Wide excision or intralesional curettage, along with adjuvant chemical cauterisation can prevent the recurrence of gct. Giant cell tumor of bone is a benign tumor with an aggressive behavior. Giant cell tumor of bone gct is a destructive and potentially metastatic bone tumour in which the characteristic giant cells have classically been considered the culprits in bone destruction. The multinucleated giant cells appear similar to osteoclasts, which led to the older term osteoclastoma 2. Ten tumors were recurrent and 16 were treated at initial presentation.
814 304 634 1031 1479 331 624 458 1552 1317 372 252 1361 22 863 1417 185 291 604 753 708 866 898 140 1488 647 1522 438 1291 678 775 1098 1302 1124 298 570 592 18 1464 1462 242